Condition (MeSH)
Meningitis, Pneumococcal
ClinicalTrials.gov lists 4 trials for Meningitis, Pneumococcal or a narrower condition beneath it. Wyeth is now a wholly owned subsidiary of Pfizer has the most among industry and government lead sponsors, with 1.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
4 of the 4 trials are tagged with Meningitis, Pneumococcal itself; the rest are tagged with a narrower condition beneath it.
When did Meningitis, Pneumococcal trials start? (4)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 2
- Phase 4
- Observational
Top of scale: 1
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2018 | 1 |
| 2011 | 1 |
| 2004 | 1 |
| 2002 | 1 |
No forecast is made for this condition: it averages 0.0 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 4 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Meningitis, Pneumococcal trials in? (3)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 2 | 1 |
| Phase 4 | 1 |
| Observational | 2 |
How many Meningitis, Pneumococcal trials are recruiting? (2)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Completed | 3 |
| Terminated | 1 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Meningitis, Pneumococcal trials? (1)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Wyeth is now a wholly owned subsidiary of Pfizer | 1 |
Which publications cover Meningitis, Pneumococcal? (21)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| High Mortality Due to Pneumococcal Meningitis in Children With Sickle Cell Disease: A French Multicenter Observational Study From 2001 to 2021. | The Pediatric infectious disease journal | 2025 | Yes |
| Addition of daptomycin for the treatment of pneumococcal meningitis: protocol for the AddaMAP study. | BMJ open | 2023 | Yes |
| Relationship between serotypes, disease characteristics and 30-day mortality in adults with invasive pneumococcal disease. | Infection | 2022 | Yes |
| Real-time whole genome sequencing direct diagnosis of Streptococcus pneumoniae meningitis: A case report. | The Journal of infection | 2021 | Yes |
| Induced hypothermia in severe bacterial meningitis: a randomized clinical trial. | JAMA | 2013 | Yes |
Showing 5 of 21 publications.
Rare-disease identity (2)
Shown in this order: exact, broader, narrower, other.
| Orphanet disease | ORPHA code | Relation | Source |
|---|---|---|---|
| Pneumococcal meningitis | 55655 | Exact | Orphanet Rare Disease Ontology (ORDO) |
| Pneumococcal meningitis | 55655 | Exact | Orphadata Science knowledge files, Product 1 |
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials, prevalence, and sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.